These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3144603)

  • 1. Serum lipids and lipoproteins in schizophrenic patients receiving major tranquilizers.
    Shafique M; Khan IA; Akhtar MH; Hussain I
    J Pak Med Assoc; 1988 Oct; 38(10):259-61. PubMed ID: 3144603
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
    Balon R; Berchou R; Zethelius M
    Can J Psychiatry; 1987 Mar; 32(2):149-50. PubMed ID: 3567823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of deep vein thrombosis associated with antipsychotic drug use.
    Matsumoto M; Konno T; Tamba K; Abe T; Kato S; Kajii E
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):450-1. PubMed ID: 15298663
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo differentiation of cardiac vagal blocking effects of chlorpromazine and haloperidol.
    Schreiber G; Belmaker RH
    Biol Psychiatry; 1987 Nov; 22(11):1417-21. PubMed ID: 3663793
    [No Abstract]   [Full Text] [Related]  

  • 5. Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients.
    Raskind MA; Courtney N; Murburg MM; Backus FI; Bokan JA; Ries RK; Dorsa DM; Weitzman RE
    Biol Psychiatry; 1987 Apr; 22(4):453-62. PubMed ID: 3567260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of chlorpromazine and haloperidol on serum lipid levels and on atherogenesis in cholesterol fed rabbits.
    Saku K; Sasaki J; Arakawa K
    Artery; 1989; 16(3):151-8. PubMed ID: 2730348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
    Jones B; Lehmann HE; Saxena BM; Ban TA
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):276-8. PubMed ID: 4969832
    [No Abstract]   [Full Text] [Related]  

  • 8. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J
    Encephale; 1993; 19(1):17-21. PubMed ID: 8275889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo study of the mutagenicity of biperidine, pipotiazine, chlorpromazine, and haloperidol.
    Smith M; de Souza MA; Pugliese S; Mari Jde J
    Am J Med Genet; 1996 Apr; 67(2):238. PubMed ID: 8723058
    [No Abstract]   [Full Text] [Related]  

  • 10. Resolution of chlorpromazine-induced pigmentation with haloperidol substitution.
    Thompson TR; Lal S; Yassa R; Gerstein W
    Acta Psychiatr Scand; 1988 Dec; 78(6):763-5. PubMed ID: 3223334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
    Singh MM
    Dis Nerv Syst; 1976 Apr; 37(4):191-6. PubMed ID: 767080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyponatremia of therapeutic origin. Apropos of a case].
    Assal F; Chauchot F
    Encephale; 1994; 20(5):527-9. PubMed ID: 7828516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Updating haloperidol: 1975].
    Ayd FJ
    Acta Physiol Lat Am; 1978 Sep; 24(3):233-8. PubMed ID: 751446
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
    Gallant DM; Bishop M; Guerrero-Figueroa R
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:53-60. PubMed ID: 4860981
    [No Abstract]   [Full Text] [Related]  

  • 15. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients.
    Ishizaki T; Chiba K; Saito M; Kobayashi K; Iizuka R
    J Clin Psychopharmacol; 1984 Oct; 4(5):254-61. PubMed ID: 6149238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of injectable haloperidol and chlorpromazine.
    Ritter RM; Davidson DE; Robinson TA
    Am J Psychiatry; 1972 Jul; 129(1):78-81. PubMed ID: 4556089
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.
    Breitbart W; Marotta R; Platt MM; Weisman H; Derevenco M; Grau C; Corbera K; Raymond S; Lund S; Jacobson P
    Am J Psychiatry; 1996 Feb; 153(2):231-7. PubMed ID: 8561204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sitosterol administration in normal and hypercholesteremic subjects; the effect in man of sitosterol therapy on serum lipids and lipoproteins.
    SACHS BA; WESTON RE
    AMA Arch Intern Med; 1956 Jun; 97(6):738-52. PubMed ID: 13312715
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
    Roncoroni D
    Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.